W. Day
The Lancet · 2011
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from W. Day's perspective
Ordered by how strongly the researchers W. Day trusts endorse each paper. Same corpus, a different order for every researcher.
- Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (The Lancet)
- Analysis of Incomplete Multivariate Data (Monographs on Statistics and Applied Probability, No. 72)
- Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. (New England Journal of Medicine)
- Prevalence and trends in obesity among US adults, 1999-2008. (Journal of the American Medical Association (JAMA))
- Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. (Journal of the American Dietetic Association)
- Bariatric surgery: a systematic review and meta-analysis. (Journal of the American Medical Association (JAMA))
- Statistical Analysis With Missing Data
- Intention to treat in clinical trials
- Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. (The Lancet)
Their papers
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. (2011) — 878 citations
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) (2011) — 629 citations